Hematopoietic stem cell transplantation and implications for cell therapy reimbursement.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21624804.
- Also identified by DOI 10.1016/j.stem.2011.05.013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As costly stem cell treatments progress from experimental concepts toward licensed products and routine procedures, governmental and private payers grapple with shrinking budgets to cover more lives. We describe efforts underway in the US to create mechanisms for reimbursement of cell therapies and discuss other reimbursement-related issues for the stem cell community.
Medical subject headings
- Cell- and Tissue-Based Therapy
- Hematopoietic Stem Cell Transplantation